by Jason Brandt (@jasondmg3)
I don’t understand any of this stuff.
Who has the time to really use this stuff anyway?
No real business can afford to have employees wasting their time on this stuff when they should be busy working.
It’s just a geek thing. Nobody with a life really uses this stuff.
It’s just a kid thing. [...]
Tags:business·communication·Digital Tools·Education·engagement·Facebook·FDA·Health care·healthcare·information·innovation·marketing·Patients·Pharmaceutical industry·social media·Social network·Trends
by Russ Ward (@russcward)
Browse through the business press, and you won’t have to search long before you find articles about pharma, patents and a whole lot of drama. From a patient perspective, what’s the big deal?
The issue: Within the next few years, multiple pharma companies are set to lose their exclusive production rights to some [...]
Tags:drug patents·Legal Issues·marketing·patent·patents·patient·Patients·Pharma·Pharmaceutical industry·Trends
Today’s guest post comes from Ken Thorlton, SVP, Creative Director, of HealthEd. Ken has been with HealthEd since 2004, now serving as senior vice president, creative services. In this role, he manages design teams and oversees all aspects of creative development—interpreting clients’ communication strategies, visually capturing patient insights and needs, and unifying that vision into [...]
Tags:Compliance·Design·Education·health literacy·patient·Patients·Thought Leaders·user needs
Ceci Zak of Sanofi speaks to Alice An at Digital Pharma East, after her presentation on the focus on consumer-centric marketing in pharma.
Tags:#digpharm·Ceci Zak·DigitalPharma East·patient·Patients·Pharma·Pharmaceutical industry·Sanofi
Joe Hogan of Epion Health talks about putting tablets at the point of care at Digital Pharma East 2011.
Tags:#digpharm·Conferences·Digital Pharma East·digital pharma east 2011·engagement·Health·Health care·healthcare·innovation·patient·Patients·tablets·Trends·User Experience
Started in 1996, Cysticfibrosis.com connects a large audience who can’t come together in real life. Here she talks with Pixels & Pills host Alice An, at Digital Pharma East 2011, about the evolution of the site.
Tags:#digpharm·Communities·community·Cystic Fibrosis·cysticfibrosis.com·Digital Pharma East·Jeanne Barrett·patient communities·patient education·patient engagement·patient portal·Patients·user needs
Jane Sarasohn-Kahn (@healthythinker) talks about how macro and microeconomics affect people’s attitudes towards healthcare.
Tags:#sxsh·economics·Education·events·Health·healthcare·Patients·social health unconference·Thought Leaders
by Sven Larsen (@zemoga)
Electronic health records (EHRs) are widely seen as a way to standardize patient data in a way that improves accuracy and drives down costs – which is why the federal government is offering financial incentives to physicians who get on board now, and will eventually levy penalties against those who do not, [...]
Tags:Digital Tools·Education·EHR·Electronic health record·electronic health records·electronic medical records·EMR·patient·patient communities·Patients·Trends
by Jason Brandt (@jasondmg3)
Are patients the mega opinion leaders of the future?
Thanks to increasing accessibility and availability of information, patients are becoming experts on their diseases. When they talk to doctors, they are educated and often know what they need or the options available to them. More patients head online to learn about their condition [...]
Tags:communication·digital strategy·empowerment·KOL·mhealth·patient·Patients·Pharma·Pharmaceutical industry·strategy·Trends
by Krissy Goelz (@krisgoelz)
How do you market the new hotness – when it is neither new nor hot anymore?
It’s a pressing issue for pharmaceutical companies, which have become increasingly dependent on blockbuster drugs (the equivalent of tentpole movies in the film industry) for long-term financial performance and market share.
But in a world bound by patents [...]
Tags:drug development·drug discovery & development·drug patents·drugs·marketing·patent·patents·Patients·Pharma·Pharmaceutical industry·research
